Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine
This study is not yet open for participant recruitment.
Verified October 2012 by Butantan Institute
Sponsor:
Butantan Institute
Collaborators:
Banco Nacional de Desenvolvimento Economico e Social
Fundação de Amparo a Pesquisa do Estado de Sao Paulo
Butantan Foundation
Information provided by (Responsible Party):
Butantan Institute
ClinicalTrials.gov Identifier:
NCT01696422
First received: September 27, 2012
Last updated: October 3, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | May 2018 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |